534 related articles for article (PubMed ID: 15078254)
21. [Dynamic anti-Proteus immunity in plasma donors during plasmapheresis].
Nazarchuk LV; Fedorovskaia EA
Vrach Delo; 1991 May; (5):35-8. PubMed ID: 1866911
[TBL] [Abstract][Full Text] [Related]
22. Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis.
Woolf K; Manore MM
J Am Diet Assoc; 2008 Mar; 108(3):443-53; discussion 454. PubMed ID: 18313425
[TBL] [Abstract][Full Text] [Related]
23. Effect of frequent blood donations on iron stores of non anaemic male blood donors.
Badar A; Ahmed A; Ayub M; Ansari AK
J Ayub Med Coll Abbottabad; 2002; 14(2):24-7. PubMed ID: 12238342
[TBL] [Abstract][Full Text] [Related]
24. Plasma glycoprotein V levels in the general population: normal distribution, associated parameters and implications for clinical studies.
Aleil B; Meyer N; Wolff V; Kientz D; Wiesel ML; Gachet C; Cazenave JP; Lanza F
Thromb Haemost; 2006 Oct; 96(4):505-11. PubMed ID: 17003930
[TBL] [Abstract][Full Text] [Related]
25. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
[TBL] [Abstract][Full Text] [Related]
26. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
[TBL] [Abstract][Full Text] [Related]
27. The effects of automated plasmapheresis on clinical, haematological, biochemical and coagulation variables in horses.
Feige K; Ehrat FB; Kästner SB; Wampfler B
Vet J; 2005 Jan; 169(1):102-7. PubMed ID: 15683770
[TBL] [Abstract][Full Text] [Related]
28. Influence of long-term plasmapheresis on blood coagulation.
Grgicević D
Ric Clin Lab; 1983; 13(1):21-31. PubMed ID: 6407088
[TBL] [Abstract][Full Text] [Related]
29. Protein levels and plasmapheresis intensity.
Ciszewski TS; Ralston S; Acteson D; Wasi S; Strong SJ
Transfus Med; 1993 Mar; 3(1):59-65. PubMed ID: 8038898
[TBL] [Abstract][Full Text] [Related]
30. [Intensive plasmapheresis (programs, laboratory monitoring, complications)].
Malakhovskiĭ IuE; Manerov FK; Makarets BG; Pedanov EA; Romanov MG
Ter Arkh; 1989; 61(7):55-60. PubMed ID: 2588144
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada.
Garg AX; Prasad GV; Thiessen-Philbrook HR; Ping L; Melo M; Gibney EM; Knoll G; Karpinski M; Parikh CR; Gill J; Storsley L; Vlasschaert M; Mamdani M;
Transplantation; 2008 Aug; 86(3):399-406. PubMed ID: 18698242
[TBL] [Abstract][Full Text] [Related]
32. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
33. Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation.
Ganotakis ES; Vrentzos GE; Gazi IF; Papadakis JA; Jagroop A; Paraskevas KI; Nair DR; Mikhailidis DP
In Vivo; 2007; 21(4):685-94. PubMed ID: 17708367
[TBL] [Abstract][Full Text] [Related]
34. [Blood coagulation and fibrinolysis in blood donors after plasmapheresis].
Zukowska B; Kotschy M
Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):120-2. PubMed ID: 1437797
[TBL] [Abstract][Full Text] [Related]
35. Atrial natriuretic peptide serum concentration decreases in donors undergoing discontinuous plasmapheresis involving a large extracorporeal blood volume.
Karger R; Halbe M; Giffhorn-Katz S; Katz N; Kretschmer V
Transfusion; 2007 Sep; 47(9):1717-24. PubMed ID: 17725739
[TBL] [Abstract][Full Text] [Related]
36. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
[TBL] [Abstract][Full Text] [Related]
37. The Canadian Red Cross plasmapheresis donor safety program: changes in plasma proteins after long-term plasmapheresis.
Wasi S; Santowski T; Murray SA; Perrault RA; Gill P
Vox Sang; 1991; 60(2):82-7. PubMed ID: 2031342
[TBL] [Abstract][Full Text] [Related]
38. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
Phelan PJ; O'Kelly P; Walshe JJ; Conlon PJ
Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
[TBL] [Abstract][Full Text] [Related]
39. Plasma fractionation in blood transfusion service.
Haskó F; Salamon M; Bartha K; Dobó P
Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
[TBL] [Abstract][Full Text] [Related]
40. [Effects of two Sicilian red wines on some cardiovascular risk factors].
Avellone G; Di Garbo V; Campisi D; Alonzo G; Gambino L; Avellone G; De Simone R; Raneli G; Novo S
Ital Heart J Suppl; 2004 May; 5(5):382-8. PubMed ID: 15182065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
